Evidence map›Paper›PMID 34869630›Full record

ArticleFrontiers in cardiovascular medicine2021

The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention.

Lele Cheng, Zixuan Meng, Qi Wang, Zhijie Jian, Pengcheng Fan, Xinxin Feng, Xiangrui Qiao, Jian Yang, Zuyi Yuan, Bolin Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Lele ChengDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Zixuan MengDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Qi WangFirst Affiliated Hospital of Xinjiang Medical University, Ürümqi, China.
Zhijie JianDepartment of Medical Imaging, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Pengcheng FanDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Xinxin FengDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Xiangrui QiaoDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Jian YangDepartment of Medical Imaging, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Zuyi YuanDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Bolin LiDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Yue WuDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
First Affiliated Hospital of Xi'an Jiaotong University · CNMinistry of Education of the People's Republic of China · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation and nutrition as main factors can affect the prognosis of patients with chronic total coronary occlusion (CTO) undergoing percutaneous coronary intervention (PCI). The C-reactive protein to albumin ratio (CAR) can clarify the inflammation and nutrition status, which are highly related to clinical outcomes. This study aims to investigate the association between CAR and adverse cardiovascular events in patients with CTO undergoing PCI. For this study, 664 patients were divided into three groups based on the tertiles of CAR. The primary endpoint was all-cause mortality and the secondary endpoint was major adverse cardiovascular events (MACE). Over a median follow-up of 33.7 months, the primary endpoint occurred in 64 patients (9.6%) and the secondary endpoint occurred in 170 patients (25.6%). The patients with higher CAR represented a worse prognosis with all-cause death and cardiovascular death after the adjustment for the baseline risk factors. Adding the CAR values raised the predictive value for the incidence of the all-cause death and cardiovascular death but not MACE. The capacity of prognosis prediction was improved after the addition of the CAR value to the traditional prediction model.

Indexed as

adverse cardiovascular eventschronic coronary total occlusionc-reactive protein to albumin ratiopercutaneous coronary interventionprognostic indicator

Identifiers

PMID34869630
PMCPMC8636141
OpenAlexW3212500004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.